This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Uday Kishore: Innovator in Eosinophil Modulation
Introduction
Uday Kishore is a prominent inventor based in Delhi, India. He has made significant contributions to the field of medical research, particularly in the modulation of eosinophil activity. His innovative work has the potential to impact various diseases and disorders associated with eosinophilia.
Latest Patents
Uday Kishore holds a patent for his invention titled "Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic eosinophils." This patent describes a formulation that utilizes surfactant protein-D (SP-D) to modulate the activity of human eosinophils derived from hypereosinophilic patients. The invention aims to increase the activation state and apoptosis of eosinophils, which can be beneficial in treating eosinophilic inflammations in various diseases, including neuromuscular and respiratory conditions, hypereosinophilic leukemias, and skin diseases.
Career Highlights
Uday Kishore is affiliated with the Council of Scientific and Industrial Research, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing complex medical issues related to eosinophil activity.
Collaborations
Uday has collaborated with notable colleagues, including Lakshna Mahajan and Taruna Madan, to further advance his research and explore new avenues in the field of eosinophil modulation.
Conclusion
Uday Kishore's contributions to the field of medical research, particularly through his patent on eosinophil modulation, highlight his role as an innovator. His work has the potential to lead to significant advancements in the treatment of eosinophilic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
